Licania michauxii Prance root extract induces hsp 70 mRNA and necrotic cell death in cultured human hepatoma and colon carcinoma cell lines

Cancer Letters

Volumn 149, Issue 1-2, 2000, Pages 61-68

  Badisa, Ramesh Babu ^a   Chaudhuri, Swapan K ^b   Pilarinou, Elsa ^b   Rutkoski, Nancy J ^b   Hare, Joan ^a   Levenson, Cathy W ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

^b Walker Cancer Research Institute   (United States)

Author keywords

Apoptosis; Caco 2; Cytotoxicity; HepG2; hsp 70; Necrosis; p53

Indexed keywords

CYTOTOXIC AGENT; HEAT SHOCK PROTEIN 70; LICANIA MICHAUXII EXTRACT; MESSENGER RNA; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL NUCLEUS; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG ISOLATION; HEAT TREATMENT; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIVER CELL CARCINOMA; NECROSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

CELL DEATH; COLONIC NEOPLASMS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LIVER NEOPLASMS; PLANT EXTRACTS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0033982667     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00347-X     Document Type: Article

References (31)

1. Hezari M., Lewis N.G., Croteau R. Purification and characterization of taxa-4(5). 11(12)-diene synthase from pacific yew (Taxus brevifolia) that catalyzes the first committed step of taxol biosynthesis. Arch. Biochem. Biophys. 322:1995;437-444.
2. Banerjee S., Upadhyay N., Kukreja A.K., Ahuja P.S., Kumar S., Saha G.C., Sharma R.P., Chattopadhyay S.K. Taxanes from in vitro cultures of the Himalayan yew Taxus wallichiana. Planta Med. 62:1996;329-331.
3. Jha S., Sanyal D., Ghosh B., Jha T.B. Improved taxol yield in cell suspension culture of Taxus wallichiana. Planta Med. 64:1998;270-272.
4. Westerlund A., Hujanen E., Hoyhtya M., Puistola U., Turpeenniemi-Hujanen T. Ovarian cancer cell invasion is inhibited by paclitaxel. Clin. Exp. Metastasis. 15:1997;318-328.
5. Markman M. Current status and future directions of platinum/paclitaxel-based chemotherapy of ovarian cancer. Semin. Oncol. 24:1997;S1124-S1127.
6. Kouroussis C., Androulakis N., Kakolyris S., Souglakos J., Kotsakis T., Mavroudis D., Katsogridakis K., Vardakis N., Hatzidaki D., Samonis G., Vlachonikolis J., Georgoulias V. Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer. J. Clin. Oncol. 17:1999;862-869.
7. Herben V.M., Panday V.R., Richel D.J., Schellens J.H., Van der Vange N., Rosing H., Beusenberg F.D., Hearn S., Doyle E., Beijinen J.H., Ten Bokkel W.W. Huinink Phase I and pharmacological study of the combination of paclitaxel, cisplatin, and topotecan administered intravenously every 21 days as first-line therapy in patients with advanced ovarian cancer. J. Clin. Oncol. 17:1999;745-747.
8. Ekmekcioglu C., Feyertag J., Marktl W. Cinnamic acid inhibits proliferation and modulates brush border membrane enzyme activities in Caco-2 cells. Cancer Lett. 128:1998;137-144.
9. Kerr J.F.R., Gobe G.C., Winterford C.M., Harmon B.V. Anatomical methods in cell death. Schwartz L.M., Osborne B.A. Cell Death. 1995;1-27 Academic Press, San Diego, CA.
10. Coasta A., Villa R., Zaffaroni N., Santi S., Bearzatto A., Silvestrini R. Taxol induces apoptosis in various cancer cell lines: comparison among different methodological approaches. Eur. J. Histochem. 41:1997;69-70.
11. Li J.H., Lax S.A., Kim J., Klamut H., Liu F.F. The effect of combining ionizing and adenoviral p53 therapy in nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 43:1999;607-616.
12. Choi J.J., Yoon K.N., Lee S.K., Lee Y.H., Park J.H., Kim W.Y., Kim J.K., Kim W.K. Antitumor activity of the aqueous-alcoholic extracts from unripe cotton ball of Gossypium indicum. Arch. Pharm. Res. 21:1998;266-272.
13. Yee C.S., Kamradt J.M., Nielsen L.C., Panvinchian R., Pienta K.J. Carboplatin-induced cell death in model prostate cancer systems. Anticancer Res. 18:1998;4475-4482.
14. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:1994;4855-4878.
15. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A. Jr., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature. 356:1992;215-221.
16. Caelles C., Helmberg A., Karin M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature. 370:1994;220-223.
17. Yonish-Rouach E., Grunwald D., Wilder S., Kimchi A., May E., Lawrence J.J., May P., Oren M. p53-mediated cell death: relationship to cell cycle control. Mol. Cell. Biol. 13:1993;1415-1423.
18. Morgan W.D., Williams G.T., Morimoto R.I., Greene J., Kingston R.E., Tjian R. Two transcriptional activators. CCAAT-box transcription factor and heat shock transcription factor, interact with a human hsp 70 gene promotor. Mol. Cell. Biol. 7:1987;1129-1138.
19. Williams G.T., Morimoto R.I. Maximal stress-induced transcription from the human HSP70 promoter requires interactions with the basal promoter elements independent of rational alignment. Mol. Cell. Biol. 10:1990;3125-3136.
20. Salminen W.F. Jr., Voellmy R., Roberts S.M. Induction of hsp 70 in HepG2 cells in response to hepatotoxicants. Toxicol. Appl. Pharmacol. 141:1996;117-123.
21. Samali A., Cotter T.G. Heat shock proteins increase resistance to apoptosis. Exp. Cell Res. 223:1996;163-170.
22. Jia L., Wang X.X., Harris C.C. Hepatitis B virus X protein inhibits nucleotide excision repair. Int. J. Cancer. 80:1999;875-879.
23. Djelloul S., Forgue-Lafitte M.E., Hermelin B., Mareel M., Bruyneel E., Baldi A., Giordano A., Chastre E., Gespach C. Enterocyte differentiation is compatible with SV40 large T expression and loss of p53 function in human colonic Caco-2 cells. Status of the pRb1 and pRb2 tumor suppressor gene products. FEBS Lett. 406:1997;234-242.
24. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidium thiocyate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
25. Steiner E., Kleinappl B., Gutshi A., Marth E. Analysis pf hsp70 mRNA levels in HepG2 cells exposed to various metals differing in toxicity. Toxicol. Lett. 96-97:1998;169-176.
26. Takayama S., Xie Z., Reed J.C. An evolutionarily conserved family of Hsp 70/Hsc 70 molecular chaperone regulators. J. Biol. Chem. 274:1999;781-786.
27. Deshaies R.J., Koch B.D., Werner-Washburne M., Craig E.A., Schekman R. A subfamily of stress proteins facilitates translocation of secretory and mitochondrial precursor polypeptides. Nature. 332:1988;800-805.
28. Ciocca D.R., Fuqua S.A., Lock-Lim S., Toft D.O., Welch W.J., McGuire W.L. Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res. 52:1992;3648-3654.
29. Mosser D.D., Duchaine J., Massie B. The DNA-binding activity of the human heat shock transcription factor is regulated in vivo by hsp70. Mol. Cell. Biol. 13:1993;5427-5438.
30. Andoh H., Itoh H., Koyama K., Sato Y., Tashima Y. Heat shock protein 70 in rat liver with necrosis and regeneration induced by thioacetamide. J. Gastroenterol. 29:1994;293-298.
31. Ohtsuka K., Laszlo A. The relationship between hsp 70 localization and heat resistance. Exp. Cell Res. 202:1992;507-518.